Mark Yazid, MD
Plastic and Reconstructive Surgery · Red Bank, NJNPI 1134532005
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,623 of the $4,815 with a category attached, or 75.3%. 18 manufacturers reported payments, led by AbbVie at 53.1% of the total. Reporting peaked in 2023 at $1,409 and has fallen 57.9% since, to $592 in 2025.
Across 66 payments — averaging $72.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Arthrex$1K
- Integra Lifesciences Corporation$280
- Seapearl East, Inc$153
- Medtronic$146
- Amgen$116
- plus $388 from 12 others
What the payments were for
- Travel & lodging$1,01521%
- Food & beverage$3,62375%
- Other$1764%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $2,558 |
| Arthrex | 14 | $1,174 |
| Integra Lifesciences Corporation | 5 | $280 |
| Seapearl East, Inc | 2 | $153 |
| Medtronic(2 entities) | 2 | $146 |
| Amgen | 1 | $116 |
| Kerecis Limited | 3 | $82 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $74 |
| TELA Bio, Inc. | 1 | $43 |
| Acera Surgical, Inc. | 1 | $34 |
| Biotronik NRO, Inc. | 1 | $29 |
| Mentor Worldwide LLC | 1 | $23 |
| Smith+Nephew | 1 | $21 |
| Checkpoint Surgical, Inc | 1 | $20 |
| Davol Inc. | 1 | $17 |
| Motiva USA, LLC | 1 | $16 |
| Vertex | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$1,399
- NATRELLE$431
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$269
- AMNIOEXCEL$176
- STRATTICE$132
- ALLODERM$131
- HawkOne$118
- TEPEZZA$116
How this compares
$4,815 in reported general payments places this provider in the 75th percentile of 93 plastic and reconstructive surgery providers in New Jersey.
See all plastic and reconstructive surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 31 | $125 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $53 |
| Tramadol Hcl | 22 | $40 |
| Oxycodone Hcl | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Red Bank
- John TaylorRed Bank$18K
- Peter AndrawesRed Bank$11K
- Chrisovalantis LakhianiRed Bank$7K
- Matthew KaufmanRed Bank$7K
- Michael RoseRed Bank$4K
- Tushar PatelRed Bank$2K
- Andrew ElkwoodRed Bank$2K
- Sara ColeCherry Hill$63K
- Edward LeeRahway$50K
- Eric ChangFlorham Park$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.